Sparteine oxidation polymorphism in Greenlanders living in Denmark

British Journal of Clinical Pharmacology
K Brøsen

Abstract

Sparteine oxidation appeared to be polymorphic in 185 healthy Greenlanders living in Denmark. Six subjects (3.2%) were phenotyped as poor metabolizers (PM) and 179 subjects as extensive metabolizers (EM). The metabolic ratio (MR) between sparteine and 2- + 5-dehydrosparteine in a 12 h urine sample ranged from 0.06-3.12 in EM and from 30-480 in PM. The excretion of dehydrosparteines accounted for less than 2.2% of the dose in PM and ranged from 5.6%-63% in EM. The urinary recovery (% of dose) of sparteine, 2-dehydrosparteine and total sparteine + dehydrosparteines was lower in Greenlander EM than in Danish EM (Brøsen et al., 1985). Incomplete urine collection in a substantial proportion of the Greenlanders could explain these discrepancies.

References

Sep 1, 1979·European Journal of Clinical Pharmacology·M EichelbaumH J Dengler
Sep 1, 1979·European Journal of Clinical Pharmacology·M EichelbaumH J Dengler
Dec 1, 1985·British Journal of Clinical Pharmacology·J C McGourtyH F Woods
May 1, 1986·British Journal of Clinical Pharmacology·T D AriasT Inaba
Jun 1, 1986·British Journal of Clinical Pharmacology·K BrøsenL F Gram
Aug 1, 1986·British Journal of Clinical Pharmacology·R BrinnS V Otton
Apr 1, 1986·Clinical Pharmacology and Therapeutics·B MellströmF Sjöqvist
Jan 1, 1985·European Journal of Clinical Pharmacology·M Eichelbaum, N M Woolhouse
Nov 1, 1985·Acta Pharmacologica Et Toxicologica·K BrøsenL F Gram
Aug 1, 1982·British Journal of Clinical Pharmacology·M S LennardJ Trevethick
Sep 1, 1984·Clinical Pharmacology and Therapeutics·N M WoolhouseF Sjöqvist
Dec 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·L M Distlerath, F P Guengerich
Oct 1, 1983·Clinical Pharmacology and Therapeutics·B MellströmF Sjöqvist
Sep 1, 1982·Clinical Pharmacokinetics·W Kalow
Mar 1, 1983·Clinical Pharmacology and Therapeutics·T InabaW Kalow
Jan 1, 1982·Clinical Pharmacology and Therapeutics·A VinksW Kalow
Feb 1, 1982·Clinical Pharmacology and Therapeutics·M EichelbaumC Zekorn
Jan 1, 1982·Canadian Journal of Physiology and Pharmacology·S V OttonW Kalow
Aug 1, 1981·Clinical Pharmacology and Therapeutics·B MellströmF Sjöqvist

❮ Previous
Next ❯

Citations

Sep 1, 1994·Journal of Clinical Pharmacology·D G May
Jan 1, 1994·European Journal of Clinical Pharmacology·K Orzechowska-JuzwenkoZ Hora
Jan 1, 1989·European Journal of Clinical Pharmacology·W D PaarH J Dengler
Jan 1, 1990·Pharmacology & Therapeutics·M Eichelbaum, A S Gross
Apr 1, 1994·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·E SpinaE Perucca
Jul 25, 2000·Journal of Clinical Pharmacy and Therapeutics·N PoolsupT L Knight
Feb 1, 1990·British Journal of Clinical Pharmacology·S WanwimolrukE J Lee
Oct 16, 2014·Expert Opinion on Drug Metabolism & Toxicology·Adrián LLerenaEduardo Tarazona-Santos
Sep 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Y HoraiH J Dengler
May 1, 1991·Human & Experimental Toxicology·D K SommersJ C Avenant
Mar 1, 1997·Canadian Journal of Physiology and Pharmacology·M Jurima-RometS Geertsen
Nov 1, 1989·Clinical Genetics·B Harvald

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Journal of Clinical Pharmacology
G F PeartG M Shenfield
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
S I IslamR L Smith
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
A MahgoubR L Smith
European Journal of Clinical Pharmacology
S WanwimolrukJ R Broughton
© 2021 Meta ULC. All rights reserved